News
Q&A: Arnulf Stenzl, Scientific Congress Office Chair, on EAU19
The Annual Congress is the EAU’s flagship scientific meeting, and therefore it’s the place for innovations in how this information is communicated to its delegates. We spoke to Prof. Arnulf Stenzl (Tübingen, DE), Chairman of the Scientific Congress Office,...
PRECISION: MRI-targeted biopsy strategy leads to fewer men needing biopsy
A Magnetic Resonance Imaging (MRI)-targeted biopsy strategy results in fewer men needing biopsy, fewer biopsy cores required and more men with clinically significant cancer detected compared to standard transrectal ultrasound guided (TRUS) biopsy, according to the large international multicentre...
General Assembly: new initiatives and increasing collaboration
New initiatives and increasing collaboration, both within Europe and internationally were the key themes of the annual EAU18 General Assembly. Over the past year, the EAU has continued its engagement with the European Union (EU) and hard work in...
Leadership Course for Medical Professionals at EAU18
The EAU Young Urologists Office (YUO) will offer a special Leadership course designed for young urologists on Monday 19 March 2018 during the Annual EAU Congress to be held in Copenhagen. The Leadership for Medical Professionals Course will be from 13.00...
EAU18 Scientific Programme: From precision medicine to future prospects
Organising a five-day congress with a Scientific Programme that addresses the extensive scope of international urology can be daunting. Not for Prof. Arnulf Stenzl, Chair of the EAU Scientific Congress Committee, and his team who had brainstormed and planned...
Call for Abstracts: ESUI Vision Award 2018
The EAU Section of Urological Imaging (ESUI) is calling for abstracts for the ESUI Vision Award 2018, which will be given to the first author of the most innovative imaging study published in urology during the last year. The...
EAU17: Highlights from the Souvenir Session
Highlights of the five-day 32nd Annual EAU Congress were reported today in the concluding session with members of the EAU Scientific Committee presenting the most noteworthy developments and conclusions in prostate disease, urological cancers, systemic therapy in GU cancer,...
EAU17: Stones: Emerging data and emergency treatment
The 32nd Annual EAU Congress came to a close on Tuesday morning with its final plenary session. For three hours, delegates were updated on emerging trials, differing approaches and specialized lectures on that most urological of topics: stones. The...
EAU17: Inaccurate adverse event reporting may lead to improper treatment of sexually active men with BPH
Reporting on adverse events in clinical trials involving sexually active men with benign prostatic hyperplasia (BPH) are inaccurate and doctors fear this may lead to incorrect estimates of the treatment impact on sexual function. “Spontaneous adverse event reporting including...
EAU17: Plenary Session examines complex neuro-urological cases
The management of complex neuro-urological patients was examined today during the “Functional Urology” session, which was chaired by Prof. Fiona Burkhard (CH) and Prof. Dirk De Ridder (BE). In this Plenary Session, two patient cases were presented by Prof....
EAU17: PCa: Debates, PROMIS and heredity at fifth plenary session
On the fourth day of EAU17, delegates could once again spend a whole morning on a key urological topic. Following earlier plenary sessions on andrology, bladder cancer and BPE, Plenary Session 5 extensively covered the screening, early detection and...
EAU17: ProtecT trial shows classical risk categories don’t help
The classical risk categories used to stage prostate cancer disease do not aid clinical decision-making as much as PSA, biopsy, Gleason score, biopsy results and other measurements, according to an expert who commented during the Late-Breaking news segment of...